Epilia: Epilepsy and Community | 에필리아: 뇌전증과 사회

Search: Epilia: Epilepsy Commun Search

CLOSE

Review article

September 26, 2023

New International League Against Epilepsy Epilepsy Syndrome Classification: Classification and Definition of Epilepsy Syndromes with Onset at a Variable Age

Eun-Kee Bae

Epilia: Epilepsy Commun. 2023;5(2):45-54.

Although epilepsy syndromes have been recognized for over 50 years, no formally accepted International League Against Epilepsy (ILAE) classification of epilepsy syndromes has existed until recently. The ILAE Task Force...

Review article

September 26, 2023

Risk Evaluation and Management of Post-Stroke Epilepsy

Jung-Ick Byun

Epilia: Epilepsy Commun. 2023;5(2):55-59.

Seizure is an important complication following ischemic or hemorrhagic stroke in older adults. Post-stroke seizure can be classified as early or late according to the onset time after stroke. There...

Review article

September 26, 2023

A New Antiseizure Medication: Cenobamate

Yong-Won Shin

Epilia: Epilepsy Commun. 2023;5(2):60-64.

Cenobamate is a novel antiseizure medication approved by the U.S. Food and Drug Administration and the European Medicines Agency, offering a new therapeutic option for drug-resistant focal onset seizures. Cenobamate...

Review article

September 26, 2023

The Practical Aspects of Epilepsy Gene Panel Testing

Ji Yeon Han

Epilia: Epilepsy Commun. 2023;5(2):65-69.

During the last decade, advances in genetic technology have led to an explosion of identification of genes associated with epilepsy. A genetic diagnosis for an individual with epilepsy can clarify...

Original article

September 26, 2023

The Epilia Counseling Board: An Online Companion for Epilepsy Treatment

Sungeun Hwang, Yong Won Cho

Epilia: Epilepsy Commun. 2023;5(2):70-74.

Background: Since 2003, Epilia has provided online personalized consultations for patients with epilepsy and their families. Methods: More than 5,000 questions from the past 19 years were reviewed and analyzed...

Original article

September 26, 2023

Efficacy and Safety of Eslicarbazepine Acetate: A Single-Center Experience

Do-Hyung Kim, Young-Soo Kim, Oh-Young Kwon, et al.

Epilia: Epilepsy Commun. 2023;5(2):75-80.

Background: Eslicarbazepine acetate (ESL) is a third-generation anti-seizure drug used in patients with focal-onset seizures. This retrospective study aimed to evaluate the efficacy and safety of ESL for the treatment...

Original article

September 26, 2023

Role of Circadian Rhythm-Related Genes in Nocturnal Epilepsy

Yong-Won Shin, Sang Kun Lee, Ki-Young Jung

Epilia: Epilepsy Commun. 2023;5(2):81-87.

Background: Epileptic seizures have been observed to have a multitude of cyclic patterns. In particular, several studies have investigated circadian rhythms (i.e., the biological changes that follow a 24-hour cycle)...

Current Issue: Volume 5(2); Sep 2023

This archive contains links to the full-text of all issues of Epilia: Epilepsy Commun.

Current issue

Volume 5(2); September

All issues

Vol. 5
2023

v.5(1)
Mar 2023

v.5(2)
Sep 2023

Vol. 4
2022

v.4(1)
Mar 2022

v.4(2)
Sep 2022

Vol. 3
2021

v.3(1)
Mar 2021

v.3(2)
Sep 2021

Vol. 2
2020

v.2(1)
Mar 2020

v.2(2)
Sep 2020

Vol. 1
2019

v.1(1)
Sep 2019

Editorial Office: Department of Neurology, Keimyung University Dongsan Medical Center
1035, Dalgubeol-daero, Dalseo-gu, Daegu 42601, Korea
Tel: +82-53-258-4376 Fax: +82-53-258-4380 E-mail: epilia.journal@gmail.com

Copyright © 2023 by Korean Clinical Epilepsy Research Society.

prev

next

prev

next